Article Details
Retrieved on: 2018-04-23 05:00:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors boosted its stake in shares of Bioline RX by 227.3% in the first quarter. <b>Benchmark Capital</b> Advisors now owns 144,000 shares of the biotechnology company's stock worth $138,000 after buying an additional 100,000 shares during the last quarter. KCG Holdings Inc. boosted ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here